Sign in

CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
operating
EIN
223542636
Phone
2017502646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$34,590
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$35K Director 2 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-03-06 EPIC PHARMA LLC 10% owner Sale −773,050 $0.90 $692K 68,960,049
2014-03-06 EPIC INVESTMENTS, LLC 10% owner Sale −773,050 $0.90 $692K 68,960,049
2014-02-25 Dash Barry H Director Grant or award +220,106 $0.09 $20K 1,013,331
2014-02-25 TREPPEL JERRY Chairman of the Board Grant or award +330,159 $0.09 $30K 2,760,006
2014-02-25 NARINE JEENARINE Director Grant or award +220,106 $0.09 $20K 6,177,728
2014-02-25 Hakim Nasrat A President & CEO Grant or award +2,616,580 $0.11 $291K 11,714,141
2014-02-25 Ward Carter Julian CFO, Secretary, Treasurer Grant or award +330,159 $0.09 $30K 875,582
2014-02-25 NIGALAYE ASHOK G Chief Scientific Officer Grant or award +220,106 $0.09 $20K 12,275,289
2014-02-25 NIGALAYE ASHOK G Chief Scientific Officer Conversion +2,000,000 $0.06 $125K 14,275,289
2014-02-25 NIGALAYE ASHOK G Chief Scientific Officer Conversion · Warrants −2,000,000 $0.06 $125K 1,333,333
2014-02-25 WHITNELL JEFFREY A Director Grant or award +220,106 $0.09 $20K 977,399
2014-02-07 TREPPEL JERRY Chairman of the Board Conversion +4.24 $141,442.72 $600K 4.24
2014-02-07 TREPPEL JERRY Chairman of the Board Conversion · Convertible Note −600,000 $141,442.72 $84.9B 0
2014-02-07 Hakim Nasrat A President & CEO Conversion +100 $100,000.00 $10.0M 100
2014-02-07 Hakim Nasrat A President & CEO Conversion · Convertible Note −10,000,000 $100,000.00 $1.0e3B 0
2014-01-13 NARINE JEENARINE Director Sale −805,583 $0.18 $147K 15,341,280
2014-01-13 NIGALAYE ASHOK G Chief Scientific Officer Sale −805,583 $0.18 $147K 20,919,930
2014-01-13 EPIC PHARMA LLC 10% owner Sale −805,583 $0.18 $147K 69,733,099
2014-01-13 EPIC INVESTMENTS, LLC 10% owner Sale −805,538 $0.18 $147K 69,733,099
2013-12-05 EPIC INVESTMENTS, LLC 10% owner Sale −275,000 $0.13 $35K 71,004,867

Page 10 of 18 · 356 trades